Pelthos Therapeutics Inc. (PTHS) is a publicly traded Healthcare sector company. As of May 21, 2026, PTHS trades at $27.45 with a market cap of $90.89M and a P/E ratio of -1.16. PTHS moved -0.52% today. Year to date, PTHS is -12.55%; over the trailing twelve months it is flat. Its 52-week range spans $13.76 to $54.29. Analyst consensus is strong buy with an average price target of $57.71. Rallies surfaces PTHS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Pelthos Therapeutics Inc. (PTHS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PTHS moved -0.52% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $27.45 |
| Market Cap | $90.89M |
| P/E Ratio | -1.16 |
| EPS | $-23.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $54.29 |
| 52-Week Low | $13.76 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $16.80M |
| Net Income | $-43.32M |
| Gross Margin | 76.25% |
7 analysts cover PTHS: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $57.71.